Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Treasury Shares data on record, last reported at $402807.0 in Q1 2026.

  • On a quarterly basis, Treasury Shares changed N/A to $402807.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $402807.0, a N/A change, with the full-year FY2023 number at $403000.0, up 36.19% from a year prior.
  • Treasury Shares reached $402807.0 in Q1 2026 per OLMA's latest filing, roughly flat from $403000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for OLMA hit a ceiling of $443867.0 in Q1 2022 and a floor of $40352.0 in Q1 2024.
  • A 4-year average of $301867.1 and a median of $345230.0 in 2022 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 104.28% in 2024 and fell as far as 83.64% in 2024.
  • Tracing OLMA's Treasury Shares over 4 years: stood at $295911.0 in 2022, then skyrocketed by 36.19% to $403000.0 in 2023, then changed by 0.0% to $403000.0 in 2024, then dropped by 0.05% to $402807.0 in 2026.
  • Business Quant data shows Treasury Shares for OLMA at $402807.0 in Q1 2026, $403000.0 in Q2 2024, and $40352.0 in Q1 2024.